Quick Answer
A Certificate of Analysis (CoA) is a laboratory document that reports the analytical test results for a specific batch of a research compound. To read a CoA, focus on: the product name and batch/lot number, the label claim (stated quantity), HPLC purity, mass spectral identification, peptide content, and any residual contaminant tests such as endotoxin or heavy metals.
What Is a Certificate of Analysis?
A Certificate of Analysis is a document issued by an analytical testing laboratory that reports the quality attributes of a specific batch of a manufactured or synthesized product. For research peptides, a CoA provides evidence that the product meets stated specifications for purity, identity, and contaminant levels. The CoA is tied to a specific batch or lot number, meaning each production run has its own unique certificate.
Key Sections of a Peptide CoA
1. Product and Batch Identification
The top section of the CoA identifies the product name, catalog number, batch/lot number, date of manufacture, and the testing laboratory. This section allows researchers to trace the product back to its production run.
2. Label Claim
The label claim states the intended or expected content of the product, for example, "10 mg net weight" or "95% purity." This is the target specification against which actual results are compared.
3. Purity by HPLC
High-Performance Liquid Chromatography (HPLC) is the primary method for determining peptide purity. The CoA reports the chromatographic purity as a percentage, representing the proportion of the main peak relative to total detected compounds. Purity results above 95% or 99% are common for high-quality research peptides. The CoA should ideally include or reference the chromatogram showing the separation profile.
4. Mass Spectral Identification
Mass spectrometry (MS) confirms the molecular identity of the peptide by measuring its molecular weight. The CoA should report the observed mass and compare it to the theoretical mass. A match within an acceptable tolerance confirms that the peptide has the expected molecular formula and amino acid sequence.
5. Peptide Content / Amount Found
Peptide content (sometimes reported as "net peptide content" or "amount found") indicates the actual mass of peptide present, as determined by amino acid analysis or UV spectrophotometry. This may differ from the total powder weight because of counter-ions (e.g., TFA salts), residual water, and other non-peptide components. The "percent of label claim" compares the amount found to the stated label claim.
6. Endotoxin Testing
Bacterial endotoxin testing (using Limulus Amebocyte Lysate, or LAL) measures contamination by gram-negative bacterial lipopolysaccharides. Low endotoxin levels are important for cell-based assays and in vitro research to avoid confounding immune responses.
7. Residual Solvents and Counter-ions
Peptides synthesized by SPPS may contain residual organic solvents (such as acetonitrile from HPLC purification) and trifluoroacetic acid (TFA) counter-ions. The CoA may report these levels, which can affect experimental outcomes in sensitive assays.
How to Interpret Results
When reviewing a CoA, researchers should verify:
- Identity confirmed: Mass spectrum matches the theoretical molecular weight
- Purity meets requirements: HPLC purity is at or above the stated specification
- Amount matches label claim: Peptide content is within an acceptable percentage of the stated weight
- Contaminants within acceptable limits: Endotoxin, heavy metals, and residual solvents are below relevant thresholds
- Batch traceability: The lot number on the CoA matches the product labeling
Understanding Percent of Label Claim
Percent of label claim is calculated as: (amount found ÷ label claim) × 100. A result of 98–102% is generally considered acceptable. Values significantly outside this range may indicate manufacturing issues or analytical variability.
Conclusion
Reading a Certificate of Analysis involves understanding the key quality attributes reported for a specific batch of a research peptide: identity (by mass spectrometry), purity (by HPLC), content (amount found vs. label claim), and contaminant levels (endotoxin, residual solvents). Researchers should verify that results meet stated specifications and that batch numbers are traceable before using a compound in experiments.
Sources & References
- Snyder LR, Kirkland JJ, Dolan JW. Introduction to Modern Liquid Chromatography, 3rd ed. Wiley; 2010.
- US FDA. Guidance for Industry: Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances. https://www.fda.gov/regulatory-information/search-fda-guidance-documents
- Anderson KW, Smith PB, Muddiman DC. Advantages of Peptide Mass Spectrometry for Sequence Identification. Anal Chem. 2009;81(11):4061-4068.